Evidence map›Paper›PMID 24801284›Full record

ReviewThe Journal of membrane biology2014

Amphipols in G protein-coupled receptor pharmacology: what are they good for?

Sophie Mary, Marjorie Damian, Rita Rahmeh, Bernard Mouillac, Jacky Marie, Sébastien Granier, Jean-Louis Banères

Abstract readReview
PubMed Publisher
In one paragraph

Review in The Journal of membrane biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Amphipols for each season.The Journal of membrane biology · 2014
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sophie MaryFaculté de Pharmacie, Institut des Biomolécules Max Mousseron (IBMM), CNRS UMR 5247, Université Montpellier 1 et 2, BP 14491, 15 Avenue Charles Flahault, 34093, Montpellier Cedex 5, France.
Marjorie Damian
Rita Rahmeh
Bernard Mouillac
Jacky Marie
Sébastien Granier
Jean-Louis Banères
Centre National de la Recherche Scientifique · FRUniversité de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

G protein-coupled receptors are at a central node of all cell communications. Investigating their molecular functioning is therefore crucial for both academic purposes and drug design. However, getting the receptors as isolated, stable and purified proteins for such studies still stumbles over their instability out of the membrane environment. Different membrane-mimicking environments have been developed so far to increase the stability of purified receptors. Among them are amphipols. These polymers not only preserve the native fold of receptors purified from membrane fractions but they also allow specific applications such as folding receptors purified from inclusion bodies back to their native state. Of importance, amphipol-trapped G protein-coupled receptors essentially maintain their pharmacological properties so that they are perfectly adapted to further investigate the molecular mechanisms underlying signaling processes. We review here how amphipols have been used to refold and stabilize detergent-solubilized purified receptors and what are the main subsequent molecular pharmacology analyses that were performed using this strategy.

Indexed as

AnimalsCell MembraneHumansHydrophobic and Hydrophilic InteractionsMembrane ProteinsPolymersReceptors, G-Protein-CoupledSolubilitySolutionsSurface-Active AgentsWaterMembrane ProteinsPolymersReceptors, G-Protein-CoupledSolutionsSurface-Active AgentsWater

Identifiers

PMID24801284
OpenAlexW2126629504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.